Zai Lab Limited (ZLAB)
(Real Time Quote from BATS)
$39.22 USD
+1.17 (3.08%)
Updated Aug 5, 2025 11:12 AM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZLAB 39.22 +1.17(3.08%)
Will ZLAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZLAB
Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say
ZLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?
Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet
Other News for ZLAB
AstraZeneca succeeds in late-stage trial for myasthenia gravis therapy
ClearBridge International Growth ACWI Ex-US Strategy Q2 2025 Commentary
Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on ...
Zai Lab price target raised by $2 at Leerink, here's why